Literature DB >> 11167702

Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.

M O Moraes1, E P Sampaio, J A Nery, B C Saraiva, F B Alvarenga, E N Sarno.   

Abstract

We compare the clinical and histological data with the immunological status of a borderline leprosy patient who experienced an erythema nodosum leprosum (ENL) reaction followed by a reversal reaction (RR) after 12 weeks of anti-inflammatory treatment (pentoxifylline, PTX, 1200 mg daily). Skin biopsies, serum and blood samples were collected sequentially during the reactional episodes. At the outset of RR, the patient's lymphocytes secreted interferon (IFN) -gamma and there was a positive lymphoproliferative test in response to Mycobacterium leprae, which had been absent during ENL. The lepromin reaction reversed from negative (0 mm) at diagnosis, to positive (3 mm) 3 months after the development of RR. Tumour necrosis factor (TNF) -alpha levels in the serum decreased after 1 week of treatment and increased slightly thereafter. The immunohistochemical data for ENL showed a diffuse dermal and hypodermal infiltrate composed of mononuclear cells and neutrophils, while RR was characterized by an epithelioid granulomatous infiltrate with a marked presence of gammadelta T cells. Reverse transcription-polymerase chain reaction showed a mixed cytokine profile characterized by the expression of TNF-alpha, IFN-gamma, interleukin (IL) -6, IL-10 and IL-12 mRNA in the skin, which persisted throughout the development of ENL and RR lesions. IL-4 mRNA, first detected after 7 days of PTX treatment, was still present during RR. The results suggest the emergence of an initial Th0-like cytokine profile in ENL, typical of a state of immunoactivation, before conditions optimal for the appearance of an antigen-specific cell-mediated immune response and gammadelta T-cell migration are created.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11167702     DOI: 10.1046/j.1365-2133.2001.03970.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

2.  Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.

Authors:  Annemieke Geluk; Krista E van Meijgaarden; Louis Wilson; Kidist Bobosha; Jolien J van der Ploeg-van Schip; Susan J F van den Eeden; Edwin Quinten; Karin Dijkman; Kees L M C Franken; Elisabeth M Haisma; Mariëlle C Haks; Colette L M van Hees; Tom H M Ottenhoff
Journal:  J Clin Immunol       Date:  2013-12-27       Impact factor: 8.317

3.  Vitamin D receptor expression levels determine the severity and complexity of disease progression among leprosy reaction patients.

Authors:  D Mandal; A H H Reja; N Biswas; P Bhattacharyya; P K Patra; B Bhattacharya
Journal:  New Microbes New Infect       Date:  2015-04-16

4.  Leprosy: an overview of pathophysiology.

Authors:  Ramesh Marne Bhat; Chaitra Prakash
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-09-04

5.  Increased Langerhans cell accumulation after mycobacterial stimuli.

Authors:  A Miranda; T P Amadeu; G Schueler; F B F Alvarenga; N Duppré; H Ferreira; J A C Nery; E N Sarno
Journal:  Histopathology       Date:  2007-11       Impact factor: 5.087

6.  Gene set signature of reversal reaction type I in leprosy patients.

Authors:  Marianna Orlova; Aurélie Cobat; Nguyen Thu Huong; Nguyen Ngoc Ba; Nguyen Van Thuc; John Spencer; Yohann Nédélec; Luis Barreiro; Vu Hong Thai; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  PLoS Genet       Date:  2013-07-11       Impact factor: 5.917

7.  The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.

Authors:  Edessa Negera; Stephen L Walker; Kidist Bobosha; Yonas Bekele; Birtukan Endale; Azeb Tarekegn; Markos Abebe; Abraham Aseffa; Hazel M Dockrell; Diana N Lockwood
Journal:  Front Immunol       Date:  2018-02-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.